|
|
Drugs for End Stage Renal Failure (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 906)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Febuxostat | approved | Phase 4, Phase 2, Phase 3 | 52 | 144060-53-7 | 134018 | 111GE013 144060-53-7 2-(3-CYANO-4-ISOBUTOXY-PHENYL)-4-METHYL-5-THIAZOLE-CARBOXYLIC ACID 2-(3-Cyano-4-(2-methylpropoxy)phenyl)-4-methylthiazole-5-carboxylic acid 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid 2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid AC-425 AC1L33UC Adenuric C16H16N2O3S CHEBI:45943 CHEBI:747206 CHEMBL1164729 CID134018 D01206 DB03786 | FT-0081351 Febuxostat Febuxostat (JAN/USAN/INN) Febuxostat [USAN] Febuxostatum Fébuxostat LS-173202 MolPort-005-940-740 S1547 S1547_Selleck TEI TMX 67 TMX-67 TMX-67, Adenuric, Uloric, Febuxostat Tei 6720 Tei-6720 UNII-101V0R1N2E Uloric | |
| | 2 | | Nitroglycerin | approved, investigational | Phase 4 | 150 | 55-63-0 | 4510 | 1,2,3-Propanetrioltrinitrate 1,2,3-Propanetriyl nitrate 100292-13-5 105469-31-6 55-63-0 80066-48-4 8013-23-8 9010-02-0 AC1L1IBV Adesitrin Aldonitrin Angibid Angiolingual Angiplex Anglix Angonist Angorin Anogesic Aquo-Trimitrosan BIDD:GT0142 BRN 1802063 Blasting gelatin Blasting oil Buccal Buccard C07455 C3H5N3O9 CCRIS 4089 CHEBI:28787 CHEMBL730 CID4510 CPD-143 Cardabid Cardamist Cardinit Cardiodisco Cellegesic Chitamite Colenitral Cordipatch Corditrine Coro-Nitro D00515 D005996 DB00727 Dauxona Deponit Deponit 5 Deponit TTS 10 Deponit TTS 5 Deponit-5 Diafusor Discotrine Dynamite EINECS 200-240-8 Epinitril GTN GTN-Pohl Gepan Nitroglicerin Gilucor nitro Gilustenon Glonoin Glycerin trinitrate Glycerine trinitrate Glycerintrinitrate Glycerol trinitrate Glycerol, nitric acid triester Glyceroli trinitratis Glyceroltrinitraat Glyceroltrinitrat Glyceryl Glyceryl nitrate Glyceryl trinitrate Glycerylnitrat Glytrin HMS2094M15 HSDB 30 Herwicard Herzer IMX-150 Klavikordal LS-7741 Lenitral Lentonitrina MED-2002 MQX-503 Mi-Trates Millisrol Minitram Minitran Minitran (TN) Minitro Mionitrat Myocon Myoglycerin Myovin NG NITRO IV NK-843 NTG Natispray Neos nitro OPT Niglin Niglycon Niong Niong Retard Nirmin Nit-Ret Nitora Nitradisc Nitradisc Pad Nitradisc TTS Nitrangin Nitrek Nitriderm Nitriderm TTS Nitrine-TDC Nitro Bid Nitro Dur Nitro Dur TTS Nitro Mack Retard Nitro Retard Nitro Rorer Nitro-Bid Nitro-Dur 10 Nitro-Dur 5 Nitro-Gesanit Retard Nitro-M-Bid Nitro-Mack Retard Nitro-Par Nitro-Pflaster Nitro-Span Nitro-Time Nitro-bid (TN) Nitro-dur Nitro-dur (TN) Nitro-lent NitroBid NitroCor | NitroDur NitroMist NitroQuick NitroQuik Nitroard Nitrobaat Nitrobid Oint Nitrobukal Nitrocap NitrocapT.D NitrocapT.D. Nitrocard Nitrocerin Nitrocine Nitrocine 5 Nitroclyn Nitrocontin Nitrocontin Continus Nitrocot Nitroderm Nitroderm TTS Nitroderm TTS Ext Nitroderm TTS-5 Nitrodisc Nitrodyl Nitrodyl TTS Nitrogard Nitrogard-SR Nitroglicerina Nitrogliceryna Nitroglin Nitroglycerin Nitroglycerin (NG) Nitroglycerin ointment Nitroglycerin-ACC Nitroglycerine Nitroglycerol Nitroglyn Nitroject Nitrol Ointment Nitrolan Nitroletten Nitrolin Nitrolingual Nitrolingual Spray Nitrolowe Nitromack Retard Nitromed Nitromel Nitromex Nitromint Nitromint Aerosol Nitromint Retard Nitromist Nitromist (TN) Nitronal Aqueous Nitronet Nitrong Nitrong Retard Nitrong parenteral Nitrong-SR Nitropatch Nitropen Nitropercuten Nitroperlinit Nitroplast Nitroprol Nitropront Nitroprontan Nitrorectal Nitroretard Nitrorex Nitrospan Nitrostabilin Nitrostat Nitrovis Nitrozell retard Nysconitrine Percutol Percutol Oint Percutol Oint. Perganit Perglottal Perlinganit Plastranit Polnitrin Propane-1,2,3-triyl trinitrate RCRA waste no. P081 Ratiopharm Rectogesic SDM No. 17 SK-106N SK-866 SK-878 Soup Spirit of glonoin Susadrin Suscard Sustac Sustak Sustonit TNG Temponitrin Top-Nitro Transderm Nitro Transderm nitro Transderm-N TTS Transderm-Nitro TTS Transderm-nitro Transderm-nitro (TN) Transiderm-nitro Tridil Tridil sublin Trinalgon Trinipatch Triniplas Trinitrate, Glyceryl Trinitrin Trinitrin Tablets Trinitrina Erba Trinitrine Trinitroglycerin Trinitroglycerol Trinitrol Trinitrolong Trinitron Trinitrosan Turicard UN0143 UN0144 UN1204 UN3064 UN3319 UNII-G59M7S0WS3 Vascana Vasoglyn Vasolator Vernies Willong c0061 nitroglycerin |
| | 3 | | alemtuzumab | approved, investigational | Phase 4, Phase 1, Phase 2 | 303 | 216503-57-0 | | | | 4 | | rituximab | approved | Phase 4, Phase 2, Phase 3, Phase 1, Early Phase 1 | 1654 | 174722-31-7 | 10201696 | AntiCD20 IDEC-102 IDEC-C2B8 | Ig gamma-1 chain C region MabThera Mabthera Rituxan rituximab |
| | 5 | | Losartan | approved | Phase 4, Phase 3, Phase 2 | 282 | 114798-26-4 | 3961 | (2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol (2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol (2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol 114798-26-4 124750-99-8 (mono-potassium salt) 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI) 2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol 2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole 2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol 2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole 2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole AC1L1H3Q BIDD:GT0286 BRD-K76205745-001-02-5 BSPBio_002695 C07072 C22H23ClN6O CHEBI:6541 CHEMBL191 CID3961 CL23623 Cozaar D08146 DB00678 DUP 89 DuP 89 DuP-753 HMS1922J13 HMS2093E22 Hyzaar I14-9710 Jsp001094 KBio2_002193 | KBio2_004761 KBio2_007329 KBio3_001915 KBioGR_001611 KBioSS_002193 L000351 LOSARTAN POTASSIUM LS-78746 Lacidipine Lortaan Losartan Losartan (INN) Losartan Potassium Losartan [INN:BAN] Losartan monopotassium salt Losartic Losartic (TN) MK-954 MK954 MolPort-003-666-553 NCGC00095125-01 NCGC00095125-02 NCGC00095125-03 Oprea1_644635 SPBio_001893 SPECTRUM1504268 Spectrum2_001677 Spectrum3_000998 Spectrum4_001126 Spectrum5_001466 Spectrum_001713 UNII-JMS50MPO89 [2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol losartan losartan potassium | |
| | 6 | | Mycophenolate mofetil | approved, investigational | Phase 4, Phase 2, Phase 3, Phase 1 | 939 | 128794-94-5 | 5281078 | 115007-34-6 128794-94-5 140401-05-4 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E) AC-1562 AC1NQXZW AC1Q6O6X AR-1J6939 BB_NC-2566 C07908 C23H31NO7 CHEMBL1456 CID5281078 CellCept CellCept, RS 61443, TM-MMF, Mycophenolate mofetil Cellcept Cellcept (TN) D00752 DB00688 HMS2090A03 | HSDB 7436 I01-0898 I06-1947 LS-172272 LS-75572 ME-MPA MMF MMF CellCept(TM) MolPort-000-883-800 Munoloc Mycophenolate mofetil (JAN/USAN) Mycophenolic acid morpholinoethyl ester Mycophenylate mofetil NCGC00159459-02 NCGC00159459-03 NSC724229 R-99 RS 61443 RS-61443 RS-61443-190 S1501_Selleck TL8000648 TM-MMF UNII-9242ECW6R0 ZINC21297660 mycophenolate mofetil | |
| | 7 | | Ertapenem | approved, investigational | Phase 4, Phase 2 | 57 | 153832-46-3 | 150610 | (1R,5S,6S,8R,2'S,4'S)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid (1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid (4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid (4R,5S,6S)-3-((3S,5S)-5-((3-carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid (4R,5S,6S)-3-({(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl}sulfanyl)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (4R,5S,6S)-3-[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 153832-46-3 AC-6814 AC1L44OL CHEBI:404903 CHEMBL1359 | CID150610 D07908 DB00303 ERTAPENEM Ertapenem Ertapenem (INN) Ertapenem [INN] I06-0484 Invanz (TN) LS-187017 LS-187767 MolPort-005-935-353 UNII-G32F6EID2H |
| | 8 | | Acetylcysteine | approved | Phase 4, Phase 2, Phase 3, Phase 1 | 316 | 616-91-1 | 12035 | (2R)-2-acetylamino-3-Sulfanylpropanoic acid (R)-2-acetylamino-3-Mercaptopropanoic acid (R)-Mercapturic acid 2-Acetylamino-3-mercapto-propionate 2-Acetylamino-3-mercapto-propionic acid ACC Acetadote Acetilcisteina Acetylcysteine Acetylcysteinum Fluimicil Infantil Fluimucetin Fluimucil Flumucetin | Fluprowit L-Acetylcysteine L-alpha-acetamido-beta-Mercaptopropionic acid Lysox Mercapturic acid Mucolysin Mucomyst N-ACETYL-L-cysteine N-Acety-L-Cysteine N-Acetyl-3-mercaptoalanine N-Acetyl-L-(+)-cysteine N-Acetylcysteine N-acetylcysteine NAC Parvolex Sodium 2-acetamido-3-mercaptopropionate |
| | 9 | | Colchicine | approved | Phase 4, Phase 2 | 111 | 64-86-8 | 6167, 2833 | (S)-N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide 30512-31-3 5843-86-7 64-86-8 7-alpha-H-Colchicine 7.alpha.H-Colchicine 7alphaH-Colchicine AC1L1LXO ACon1_000353 AI3-31149 AKOS001582887 BB_NC-0737 BPBio1_000535 BRD-K00259736-001-06-5 BSPBio_000485 BSPBio_002083 Benzo(a)heptalen-9(5H)-one C 9754 C07592 C22H25NO6 C3915_SIGMA C9754_SIGMA CCRIS 691 CHEBI:27882 CHEMBL107 CID6167 CPD-9785 Colchicin Colchicin [German] Colchicina Colchicina [Italian] Colchicine (JP15/USP) Colchicine (TN) Colchicine [JAN] Colchicine, (+-)-Isomer Colchicine, (R)-Isomer Colchicine, Colchicum autumnale Colchicinum Colchineos Colchisol Colchysat Colcin Colcrys Colsaloid Colstat Condylon D003078 D00570 DB01394 DB08117 DivK1c_000753 EINECS 200-598-5 EU-0100310 Goutnil HMS1569I07 HMS1920A08 HMS2091G16 HMS502F15 HSDB 3044 IDI1_000753 KBio1_000753 KBio2_001322 KBio2_003890 | KBio2_006458 KBio3_001303 KBioGR_000856 KBioSS_001322 Kolkicin LOC LS-279 Lopac0_000310 MEGxp0_001879 MLS001055448 MLS001055448-02 MLS001304089 MLS002153786 MPC-004 MolPort-001-742-594 N-((7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)- acetamide N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)acetamide N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[.alpha.]heptalen-7-yl)-acetamide N-Acetyl trimethylcolchicinic acid methylether N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]acetamide NCGC00025125-01 NCGC00025125-02 NCGC00025125-03 NCGC00025125-04 NCGC00025125-05 NCGC00025125-06 NCGC00025125-07 NCGC00025125-11 NCGC00169157-01 NCGC00169157-02 NCGC00169157-03 NCI60_041659 NChemBio.2007.10-comp20 NINDS_000753 NSC 757 NSC757 Prestwick0_000363 Prestwick1_000363 Prestwick2_000363 Prestwick3_000363 Prestwick_695 S2284_Selleck SDCCGMLS-0066633.P001 SMR000058323 SPBio_000289 SPBio_002406 SPECTRUM1500205 Spectrum2_000075 Spectrum3_000362 Spectrum4_000298 Spectrum5_000787 Spectrum_000842 Tocris-1364 UNII-SML2Y3J35T UPCMLD-DP065 UPCMLD-DP065:001 WLN: L B677 MV&T&J CO1 DO1 EO1 JMV1 NO1 ZINC00621853 binds to tubulin colchicine inhibits microtubular assembly nchembio853-comp2 spindle poison |
| | 10 | | Everolimus | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1896 | 159351-69-6 | 6442177 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy 07741_FLUKA 159351-69-6 40-O-(2-hydroxyethyl)-rapamycin 42-O-(2-Hydroxyethyl)rapamycin Afinitor CERTICAN(R) CHEMBL1201755 Certican D02714 DB01590 | Everolimus Everolimus (JAN/USAN/INN) Everolimus [USAN] LS-143292 MolPort-003-847-342 MolPort-003-925-588 NCGC00167512-01 NVP-RAD-001 RAD 001 RAD-001 RAD-001C RAD001 RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus S1120_Selleck SDZ-RAD UNII-9HW64Q8G6G Zortress everolimus |
| | 11 | | Miconazole | approved, investigational, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1 | 3624 | 22916-47-8 | 4189 | (+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole 1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole 1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole 1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole 22832-87-7 (NITRATE) 22916-47-8 75319-47-0 AB00053500 AC1L1HM1 AKOS001574474 Aflorix(nitrate) Albistat(nitrate) Andergin(nitrate) BPBio1_000279 BRD-A82396632-001-03-0 BRD-A82396632-008-02-7 BRN 0965511 BSPBio_000253 BSPBio_002033 CCRIS 7924 CHEBI:6923 CHEMBL91 CID4189 CPD-4501 Conofite(nitrate) D00416 DB01110 Dactarin Daktarin IV Daktarin iv DivK1c_000156 EINECS 245-324-5 Epi-Monistat(nitrate) Femizol-M Florid(nitrate) Gyno-Daktar(nitrate) HMS1568M15 HMS2090B21 I14-14342 IDI1_000156 Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI) KBio1_000156 KBio2_001445 KBio2_004013 KBio2_006581 KBio3_001533 KBioGR_000581 KBioSS_001445 LS-78378 Lotrimin AF(nitrate) MCZ MJR 1762 MLS002222203 Micantin (nitrate) Miconasil Nitrate | Miconazol Miconazol [INN-Spanish] Miconazole Miconazole (JP15/USP/INN) Miconazole 3 Miconazole 3 Combination Pack Miconazole 7 Combination Pack Miconazole [USAN:BAN:INN:JAN] Miconazole nitrate salt Miconazole-7 Miconazolo Miconazolo [DCIT] Miconazolum Miconazolum [INN-Latin] Micozole Minostate MolPort-002-557-553 Monazole 7 Monista (nitrate) Monistat Monistat (TN) Monistat 1 Combination Pack Monistat 3 Dual-Pak Monistat 3 Vaginal Ovules Monistat 5 Tampon Monistat 7 Dual-Pak Monistat 7 Vaginal Suppositories Monistat Dual- PAK Monistat IV Monistat iv (TN) Monistat iv (tn) Monistat-Derm NCI60_001353 NCI60_001380 NINDS_000156 NSC 170986 NSC169434 NSC170986 Novo-Miconazole Vaginal Ovules Oprea1_091955 Prestwick0_000067 Prestwick1_000067 Prestwick2_000067 Prestwick3_000067 Prestwick_335 R 18134 R-14,889 SMR001307249 SPBio_000976 SPBio_002174 STK834405 STOCK1S-93556 Spectrum2_001048 Spectrum3_000507 Spectrum4_000061 Spectrum5_001297 Spectrum_000965 UNII-7NNO0D7S5M Vusion Zimycan imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI) miconazole | |
| | 12 | | Sirolimus | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 1896 | 53123-88-9 | 5284616, 6436030, 46835353 | (-)-Rapamycin (-)-rapamycin 1fkb 1pbk 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone 53123-88-9 A422989, NSC226080 AC-722 AC1L1JH9 AC1L7MJ9 AC1L9ZMV AY 22989 AY-22989 AY22989 Ambotz53123-88-9 Antibiotic AY 22989 BIDD:PXR0165 Bio1_000293 Bio1_000782 Bio1_001271 Bio2_000375 Bio2_000855 BiomolKI2_000084 C07909 C51H79NO13 CBiol_002007 CCRIS 9024 CHEBI:100923 CHEBI:9168 CHEMBL413 CID10213190 CID10795871 CID11949238 CID11959112 CID313006 CID478951 CID5040 CID5284616 CID5358081 CID5374464 CID5460439 CID5497196 CID5924240 CID6436030 CID6610270 CID6610346 CID6711160 CID6713081 CID9833581 CID9854379 CID9854380 CID9962926 CID9962928 D00753 DB00877 DE-109 DivK1c_006936 | FT-0082351 HMS2089A21 HSDB 7284 KBio1_001880 KBio2_000410 KBio2_002978 KBio2_005546 KBio3_000779 KBio3_000780 KBioGR_000410 KBioSS_000410 LCP-Siro LMPK06000003 LS-143290 MLS000028373 MS-R001 MolMap_000043 MolPort-003-959-433 NCGC00021305-05 NCI60_001851 NCIMech_000355 NSC 226080 NSC226080 Perceiva QTL1_000069 R0395_SIAL R0395_SIGMA RAP RAPA RPM Rapammune Rapamune Rapamune (TN) Rapamycin Rapamycin (TN) Rapamycin C-7, analog 4 Rapamycin Immunosuppressant Drug Rapamycin from Streptomyces hygroscopicus S1039_Selleck SIIA 9268A SILA 9268A SILA9268A SMP1_000255 SMR000058564 Sirolimus Sirolimus (RAPAMUNE) Sirolimus (USAN/INN) Sirolimus [USAN:BAN:INN] Sirolimus, Rapamune,Rapamycin SpecPlus_000840 UNII-W36ZG6FT64 UNM-0000358684 WY-090217 Wy 090217 heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy nchembio.100-comp4 nchembio.2007.42-comp2 nchembio.79-comp1 nchembio762-comp1 nchembio883-comp3 rapamycin sirolimus |
| | 13 | | Iron | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1123 | 7439-89-6 | 23925 | 02583_FLUKA 12310_ALDRICH 12310_RIEDEL 129048-51-7 14067-02-8 161135-39-3 190454-13-8 195161-83-2 199281-22-6 209309_ALDRICH 209309_SIAL 255637_ALDRICH 266213_ALDRICH 266256_ALDRICH 267945_ALDRICH 267953_ALDRICH 26Fe 338141_ALDRICH 356808_ALDRICH 356824_ALDRICH 356832_ALDRICH 39344-71-3 3ZhP 413054_ALDRICH 443783-52-6 44890_ALDRICH 44890_FLUKA 675141-17-0 70884-35-4 73135-38-3 7439-89-6 8011-79-8 8053-60-9 AC1L2N38 ATW 230 ATW 432 Ancor B Ancor en 80/150 Armco iron Atomel 28 Atomel 300M200 Atomel 500M Atomel 95 Atomiron 44MR Atomiron 5M Atomiron AFP 25 Atomiron AFP 5 C00023 C3518_SIAL C3518_SIGMA CCRIS 1580 CHEBI:18248 CID23925 Carbonyl iron Copy Powder CS 105-175 D007501 DB01592 DSP 1000 DSP 128B DSP 135 DSP 135C DSP 138 Diseases (animal), iron overload Diseases, iron overload EF 1000 EF 250 EFV 200/300 EFV 250 EFV 250/400 EINECS 231-096-4 | Ed-In-Sol Eisen Electrolytic iron F 60 (metal) FE FT 3 (element) Fe Fe-40 Fe1+ Feronate Ferretts Ferro-Caps Ferro-Time Ferrousal Ferrovac E Ferrum Ferrum metallicum GS 6 HF 2 (element) HL (iron) HQ (metal) HS (iron) HS 4849 HSDB 604 Hemocyte Hierro Hoeganaes ATW 230 Hoeganaes EH IRMM524A_FLUKA IRMM524B_FLUKA IRON Iron (Fe) Iron (Fe1+) Iron ion (Fe+) Iron ion(1+) Iron monocation Iron powder Iron standard for AAS Iron(1+) Iron(1+) ion Iron(III) nitrate solution Iron, carbonyl Iron, electrolytic Iron, elemental Iron, ion (Fe1+) Iron, ion (Fe1+) (8CI,9CI) Iron, reduced LOHA LS-3196 MolPort-003-925-001 NC 100 PZh-1M3 PZh-2 PZh1M1 PZh2M PZh2M1 PZh2M2 PZh3 PZh3M PZh4M PZhO Reduced iron Remko SUY-B 2 Siderol UNII-E1UOL152H7 Vitedyn-Slo Yieronia fer ferrous iron hierro | |
| | 14 | | Tacrolimus | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 1074 | 104987-11-3 | 445643, 439492 | (-)-FK 506 (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone 104987-11-3 109581-93-3 (Hydrate) 15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone, 3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN AC-1182 AC1L1K7H AC1L97GB AC1L9IBU AKOS005145901 Advagraf Ambap104987-11-3 Ambap5429 Anhydrous tacrolimus BCBcMAP01_000194 BRD-K35452788-001-02-1 BSPBio-001279 BSPBio_001279 Bio-0921 Bio2_000470 Bio2_000950 C01375 C44H69NO10 CCRIS 7124 CHEBI:100924 CHEBI:61049 CHEMBL1200738 CID11158639 CID11556866 CID439492 CID445643 CID5372 CID5472317 CID6426916 CID6436007 CID6473866 CID6536850 CID6610362 CID6912836 CID9832283 CID9853905 CID9918805 CID9940643 CID9963169 CPD-10016 CPD000466356 D08556 DB00864 DivK1c_001040 FK 506 FK-506 FK5 FK506 FR 900506 FR-900506 | FR900506 FT-0082660 Fk-506 Fujimycin Graceptor HMS1362O21 HMS1792O21 HMS1990O21 HMS2051C18 HMS2093M19 HMS503O21 IDI1_001040 IDI1_002225 K506 KBio1_001040 KBio2_000619 KBio2_003187 KBio2_005755 KBio3_001097 KBio3_001098 KBioGR_000619 KBioSS_000619 L 679934 L-679934 LCP-Tacro LMPK04000003 LS-64247 MLS000759471 MLS001424054 Modigraf MolPort-003-666-518 NCGC00163470-01 NCGC00163470-02 NCGC00163470-03 NCGC00163470-04 NCGC00179232-01 NChemBio.2007.16-comp1 NINDS_001040 NSC717865 Prograf Prograf (TN) Protopic Protopy S5003_Selleck SAM001246677 SMR000466356 Tacarolimus Tacrolimus (INN) Tacrolimus (Prograf?) Tacrolimus (anhydrous) Tacrolimus anhydrous Tacrolimus hydrate Tacrolimus, anhydrous Tsukubaenolide UNII-Y5L2157C4J nchembio.2007.23-comp2 tacrolimus tacrolimus hydrate | |
| | 15 | | Alendronate | approved | Phase 4 | 160 | 121268-17-5, 66376-36-1 | 2088 | (4-Amino-1-hydroxybutylidene)bisphosphonic acid (4-Amino-1-hydroxybutylidene)diphosphonic acid (4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid (4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid) (4-amino-1-hydroxybutylidene)bisphosphonic acid 121268-17-5 (mono-hydrochloride salt, trihydrate) 1yhm 4-Amino-1-hydroxybutane-1,1-diphosphonate 4-Amino-1-hydroxybutane-1,1-diphosphonic Acid 4-Amino-1-hydroxybutylidene-1,1-bis(phosphonic acid) 4-Amino-1-hydroxybutylidene-1,1-bisphosphonate 4-amino-1-hydroxybutane-1,1-diphosphonic acid 66376-36-1 ABDP AC1L1CW3 AKOS001015793 ALENDRONATE SODIUM ALENDRONIC ACID Acide Alendronique Acide Alendronique [INN-French] Acide alendronique Acide alendronique [INN-French] Acido Alendronico Acido Alendronico [INN-Spanish] Acido alendronico Acido alendronico [INN-Spanish] Acidum Alendronicum Acidum Alendronicum [INN-Latin] Acidum alendronicum Acidum alendronicum [INN-Latin] Adronat | Alendronate Alendronate Sodium Alendronate sodium hydrate Alendronic acid Alendronic acid (INN) Alendronic acid [INN:BAN] Alendros Arendal BIDD:GT0180 C07752 CHEBI:2567 CHEMBL870 CID2088 D07119 DB00630 Fosamax Fosamax Plus D HSCI1_000337 LS-106421 MK 217 MK-217 MolPort-000-421-410 NCGC00096054-01 NCGC00096054-03 NCGC00096054-04 Onclast Oprea1_422906 Phosphonic acid, (4-amino-1-hydroxybutylidene)bis SPECTRUM1505166 ST50036159 UNII-X1J18R4W8P alendronate bisphosphonate, 65 |
| | 16 | | Pioglitazone | approved, investigational | Phase 4, Phase 2 | 435 | 111025-46-8 | 4829 | (+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione (+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione (+/-)-5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione (+/-)-5-[p-[2-(ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione 105355-27-9 111025-46-8 198077-89-3 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- (9CI) 5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione 5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione 5-[[4-[2-[(5-ethyl-2-pyridyl)]ethoxy]phenyl]methyl]thiazolidine- 2,4-dione 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione AB1004597 AC-1021 AC1L1J1Q AD 4833 AD-4833 Actos Actos (TN) Actost BRD-A48430263-003-02-4 BSPBio_002723 C07675 C19H20N2O3S CHEBI:8228 CHEMBL595 CID4829 D08378 DB01132 Duetact Glustin HMS2089H14 HS-0047 | HSDB 7322 I06-0089 KBio2_002103 KBio2_004671 KBio2_007239 KBio3_001943 KBioGR_001619 KBioSS_002103 LS-151327 MolPort-002-508-211 NCGC00163128-01 NCGC00163128-02 Pioglitazona Pioglitazona [INN-Spanish] Pioglitazone Pioglitazone HCl Pioglitazone Hydrochloride Pioglitazone [BAN:INN] Pioglitazone [Ban:Inn] Pioglitazone [INN:BAN] Pioglitazonum Pioglitazonum [INN-Latin] SPBio_001897 Spectrum2_001679 Spectrum3_001002 Spectrum4_001130 Spectrum5_001480 Spectrum5_002067 Spectrum_001623 U 72107 U 72107A U-72107 U72,107A UNII-X4OV71U42S Zactos nchembio790-comp10 pioglitazone (INN) pioglitazone HCl | |
| | 17 | | Lidocaine | approved, vet_approved | Phase 4 | 1226 | 137-58-6 | 3676 | .alpha.-(Diethylamino)-2,6-acetoxylidide .alpha.-Diethylamino-2,6-dimethylacetanilide .alpha.-Diethylaminoaceto-2,6-xylidide .omega.-Diethylamino-2,6-dimethylacetanilide 137-58-6 2-(Diethylamino)-2',6'-acetoxylidide 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide 2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide 4-12-00-02538 (Beilstein Handbook Reference) 6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE)) 6108-05-0 (mono-hydrochloride, mono-hydrate) 73-78-9 (mono-hydrochloride) AB00053581 AC-10282 AC1L1GGQ AC1Q2Z7J AKOS001026768 ARONIS23855 After Burn Double Strength Gel After Burn Double Strength Spray After Burn Gel After Burn Spray Alphacaine Anestacon Anestacon Jelly BIDD:GT0342 BPBio1_000197 BRD-K52662033-001-02-6 BRD-K52662033-003-05-5 BRN 2215784 BSPBio_000179 BSPBio_001359 BSPBio_003004 Bio-0767 Bio1_000379 Bio1_000868 Bio1_001357 Bio2_000079 Bio2_000559 C07073 C14H22N2O CAS-73-78-9 CDS1_000283 CHEBI:6456 CHEMBL79 CID3676 CPD000058189 Cappicaine Cito optadren Cuivasil D00358 DB00281 Dalcaine Dentipatch Dentipatch (TN) DermaFlex Diethylaminoaceto-2,6-xylidide Dilocaine DivK1c_000174 DivK1c_001323 Duncaine EINECS 205-302-8 ELA-Max EMBOLEX Emla Emla Cream Esracaine FT-0082378 Gravocain HMS1791D21 HMS1989D21 HMS2051C21 HMS2089E15 HMS548M19 HSDB 3350 I01-2704 IDI1_000174 IDI1_033829 Isicaina Isicaine Jetocaine KBio1_000174 KBio2_000079 KBio2_001598 KBio2_002647 KBio2_004166 KBio2_005215 KBio2_006734 KBio3_000157 KBio3_000158 KBio3_002224 KBioGR_000079 KBioGR_000599 KBioSS_000079 KBioSS_001598 L-Caine L0156 L1026_SIGMA L7757_SIGMA LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE) LIDOPEN LQZ | LS-805 Lanabiotic Leostesin Lida-Mantle Lidocaina Lidocaina [INN-Spanish] Lidocaine (JP15/USP/INN) Lidocaine (VAN) Lidocaine Carbonate Lidocaine Hydrocarbonate Lidocaine Monohydrochloride Lidocaine [USAN:INN:JAN] Lidocainum Lidocainum [INN-Latin] Lidocaton Lidoderm Lidoject-1 Lidoject-2 Lignocaine Lignocainum Lingocaine Lopac-L-5647 Lopac0_000669 MLS000069724 MLS000758263 MLS001074177 Maricaine Maybridge1_002571 MolPort-001-783-478 N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide NCGC00015611-01 NCGC00015611-02 NCGC00015611-03 NCGC00015611-04 NCGC00015611-14 NCGC00022176-05 NCGC00022176-06 NCGC00022176-07 NCGC00022176-08 NCGC00022176-09 NINDS_000174 NSC 40030 NSC40030 Norwood Sunburn Spray Octocaine Octocaine-100 Octocaine-50 Prestwick0_000050 Prestwick1_000050 Prestwick2_000050 Prestwick3_000050 Remicaine Rocephin Kit Rucaina S1357_Selleck SAM001247018 SMR000058189 SPBio_001525 SPBio_002100 STK552033 Solarcaine Solarcaine aloe extra burn relief cream Solcain Spectrum2_001343 Spectrum3_001392 Spectrum4_000070 Spectrum5_001549 Spectrum_001118 UNII-98PI200987 WLN: 2N2 & 1VMR B1 F1 Xilina Xilocaina Xilocaina [Italian] Xllina Xycaine Xylestesin Xylesthesin Xylocain Xylocaine Xylocaine (TN) Xylocaine 5% Spinal Xylocaine CO2 Xylocaine Dental Ointment Xylocaine Endotracheal Xylocaine Test Dose Xylocaine Viscous Xylocaine-MPF Xylocaine-MPF with Glucose Xylocaine-Mpf Xylocaine-Mpf with Glucose Xylocard Xylocitin Xyloneural (free base) Xylotox Zilactin-L Zingo alfa-Dietilamino-2,6-dimetilacetanilide alfa-Dietilamino-2,6-dimetilacetanilide [Italian] alpha-Diethylamino-2,6-dimethylacetanilide alpha-diethylamino-2,6-dimethylacetanilide lidocaine nchembio.65-comp16 α-diethylamino-2,6-dimethylacetanilide | |
| | 18 | | Acarbose | approved, investigational | Phase 4 | 85 | 56180-94-0 | 441184 | (2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol (2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4S,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol (3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol 1,4-DEOXY-4-((5-HYDROXYMETHYL-2,3,4-TRIHYDROXYCYCLOHEX-5,6-ENYL)AMINO)FRUCTOSE 1agm 1gah 1k1y 1lf9 1ukt 4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-D-glucopyranose 4,6-dideoxy-4-{[(1S,4S,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-D-glucose 56180-94-0 AC1L26GM AC1L9APL AC1L9G0J AC1L9HYX AC1NAU1X AC1OCEJZ ACI-(1-4)GLD-(1-4)GLC-(1-4)GLB ACR Acarbosa Acarbosa [INN-Spanish] Acarbose Acarbose (JAN/USAN/INN) Acarbose [USAN:BAN:INN:JAN] Acarbosum Acarbosum [INN-Latin] Alpha-Acarbose BAY-g 5421 BB_NC-1311 Bay g 5421 Bay-g-5421 Beta-Acarbose C06802 C25H43NO18 CHEBI:2376 CHEBI:506767 CHEMBL1566 | CHEMBL394434 CHEMBL569486 CID10627975 CID41774 CID441184 CID4432690 CID444254 CID445421 CPD000466376 D00216 DB00284 EINECS 260-030-7 Glucobay Glucor HMC-(1-4)AGL-(1-4)GLC-(1-4)GLC HMS2051F03 HMS2093I22 LS-71702 MLS000759506 MLS001424056 MolPort-002-507-369 MolPort-003-844-373 NCGC00096061-01 NCGC00096061-02 NCGC00160515-01 O-4,6-Dideoxy-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyranosyl-(1-4)-D-glucose O-4,6-Dideoxy-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1->4)-O-alpha-D-glucopyranosyl-(1->4)-D-glucose O-4,6-Dideoxy-4-(((1S-(1alpha,4alpha,5beta,6alpha))-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyranosyl-(1-4)-D-glucose Prandase Prandase, Precose, Glucobay, Bay-g 5421, Acarbose Precose Precose (TN) QPS S1271_Selleck SAM001246733 SMR000466376 SPECTRUM1505172 STK801930 UNII-T58MSI464G acarbose |
| | 19 | | Epoprostenol | approved | Phase 4, Phase 2, Phase 3 | 53 | 61849-14-7, 35121-78-9 | 5280427, 5282411 | (5E)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3R)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid (5Z)-5-[(4R,5R)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid (5Z,13E)-(15S)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoate (5Z,13E)-(15S)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoic acid (5Z,13E)-(15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dienoate (5Z,13E)-(15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dienoic acid (5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate (5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid (5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dienoate (5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dienoic acid (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid (5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate (5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oate (5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid (5Z,9alpha,11alpha,13E,15S)-11,15-dihydroxy-6,9-epoxyprosta-5,13-dien-1-oic acid (5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oate (5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid (5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid (Z)-(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valeric acid 136626-78-3 35121-78-9 5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid 5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid 5-[5-hydroxy-4-(3-hydroxyoct-1-enyl)-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid 6,9-alpha-Epoxy-11-alpha,15(S)-dihydroxyprosta-5(Z),13(E)-dien-1-oic acid 61849-14-7 63748-50-5 63859-31-4 AC1L18LX AC1L3FZB AC1NQX0K AC1NR00P AC1O51WG AC1O5HI7 AR-1I7150 BIDD:GT0514 BRD-K64054020-001-02-7 BRN 1690090 BSPBio_001496 Bio2_000216 Bio2_000696 C01312 CHEBI:15552 CHEMBL1139 CHEMBL307845 CID114805 CID11969614 CID159 CID5280427 CID5282411 CID6434194 CID6450541 | CID9864371 CID9975312 D00106 DB01240 Epoprostanol Epoprostenol Epoprostenol (TN) Epoprostenol (USAN/INN) Epoprostenol [USAN:INN] Epoprostenolum Epoprostenolum [INN-Latin] Flolan HMS1791K18 HMS1989K18 IDI1_033966 KB-IV-24 KBio2_000216 KBio2_002784 KBio2_005352 KBio3_000431 KBio3_000432 KBioGR_000216 KBioSS_000216 LMFA03010087 LS-125828 NCGC00161285-01 NCGC00161285-02 NCGC00161285-03 PDSP1_001721 PDSP2_001704 PG-I2 PGI(sub 2) PGI2 PGX Prostacyclin Prostacyclin I2 Prostacycline Prostacyclins Prostaglandin I Prostaglandin I(2) Prostaglandin I2 Prostaglandin X Prostaglandin x Prostaglandins X SMP2_000227 TRY 200 Try-200 U 53,217 U-53217 UNII-DCR9Z582X0 Vasocyclin epoprostenol prostacyclin prostaglandin I2 | |
| | 20 | | Nadroparin | approved | Phase 4 | 35 | 9041-08-1 | | | 21 | | Pregabalin | approved, illicit, investigational | Phase 4 | 355 | 148553-50-8 | 5486971 | (3S)-3-(aminomethyl)-5-methylhexanoic acid (R-)-3-isobutyl GABA (S)-3-(Aminomethyl)-5-methylhexanoic acid (S)-3-Isobutyl gaba (S+)-3-isobutyl GABA 121GE001 148553-50-8 3-Isobutyl gaba 3-isobutyl GABA AC-1158 AC1NUP03 AKOS005145504 C080245 C8H17NO2 CHEBI:236161 CHEMBL1059 CI 1008 CI-1008 CID5486971 | D02716 DB00230 FT-0080911 HSDB 7530 LS-75191 Lyrica Lyrica (TN) MolPort-000-861-733 PD 144723 PD-144723 Pregabalin Pregabalin (JAN/USAN/INN) Pregabalin [USAN] Pregablin S-(+)-3-isobutylgaba S1731_Selleck SBB062901 TL8001062 TOS-BB-0910 UNII-55JG375S6M | |
| | 22 | | Ritonavir | approved, investigational | Phase 4, Phase 3, Phase 2 | 870 | 155213-67-5 | 392622 | 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate 155213-67-5 1hxw 1sh9 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate 538, ABT A-84538 ABBOTT-84538 ABT 538 ABT 84538 ABT-538 ABT538 AC-733 AC1L94GB AKOS000280930 Abbott 84538 BIDD:GT0387 BIDD:PXR0023 Bio-0093 C07240 C37H48N6O5S2 CHEBI:45409 CHEMBL163 CID392622 CPD000466395 D00427 D019438 | DB00503 DRG-0244 FT-0082824 HMS2051B08 HSDB 7160 LS-148860 MLS000759541 MLS001424063 MolPort-000-883-877 N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide NCGC00159462-02 NSC693184 Norvir Norvir (TM) Norvir (TN) Norvir Sec RIT RTV Ritonavir Ritonavir (JAN/USAN/INN) Ritonavir [USAN] Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavirum S1185_Selleck SAM001246783 SMR000466395 STK634209 ZINC03944422 ritonavir | |
| | 23 | | Bupivacaine | approved, investigational | Phase 4, Phase 3 | 1131 | 2180-92-9, 38396-39-3 | 2474 | ( inverted exclamation markA)-bupivacaine (+-)-Bupivacaine (1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide (RS)-bupivacaine (±)-bupivacaine 1-Butyl-2',6'-pipecoloxylidide 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 15233-43-9 2180-92-9 38396-39-3 AB00053674 AC-2096 AC1L1DRE AC1Q5LX4 AH 250 AKOS001637202 AR-1A0242 Anekain BPBio1_000298 BRD-A01636364-003-05-2 BSPBio_000270 BSPBio_002607 Bio-0886 Bloqueina Bucaine Bucaine (TN) Bupivacaina Bupivacaina [INN-Spanish] Bupivacaine (INN) Bupivacaine Carbonate Bupivacaine HCL Bupivacaine HCL KIT Bupivacaine Monohydrochloride, Monohydrate Bupivacaine [INN:BAN] Bupivacainum Bupivacainum [INN-Latin] Bupivan C07529 C18H28N2O CBupivacaine CHEBI:3215 CHEMBL1098 CID2474 Carbostesin D07552 DB00297 DL-Bupivacaine DUR-843 | DepoBupivacaine DivK1c_000758 EINECS 218-553-3 EINECS 253-911-2 HMS2090F12 IDI1_000758 KBio1_000758 KBio2_002004 KBio2_004572 KBio2_007140 KBio3_001827 KBioGR_001516 KBioSS_002004 KST-1A4609 L000695 LAC-43 LS-109841 LS-2222 MLS001361336 Marcaina Marcaine Marcaine HCL Marcaine Spinal MolPort-004-955-820 NCGC00178579-01 NCGC00178579-02 NINDS_000758 NSC119660 Prestwick0_000305 Prestwick1_000305 Prestwick2_000305 Prestwick3_000305 SMR000058218 SPBio_001558 SPBio_002489 Sensorcaine Sensorcaine-MPF Sensorcaine-MPF Spinal Spectrum2_001589 Spectrum3_000974 Spectrum4_001098 Spectrum5_001483 Spectrum_001524 Transdur-Bupivacaine UNII-Y8335394RO Win 11318 Win 11318 HCl bupivacaine cBupivacaine dl-1-Butyl-2',6'-pipecoloxylidide racemic bupivacaine |
| | 24 | | Candesartan | approved | Phase 4, Phase 3 | 156 | 139481-59-7 | 2541 | 139481-59-7 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid 2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid 2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid 2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid 2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid 2-Ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl] methyl]-3H-benzoimidazole-4-carboxylic acid 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benzimidazole-7-carboxylic acid 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl}-1H-benzimidazole-7-carboxylic acid 2-ethoxy-3-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]-3h-benzoimidazole-4-carboxylic acid 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid 2-ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole AC-203 AC1L1DWT Amias Atacand Atacand, Blopress, Amias, Ratacand,Candesartan BIDD:GT0350 Blopress Blopress (TN) C07468 C081643 C24H20N6O3 CHEBI:216848 | CHEBI:3347 CHEMBL1016 CID2541 CV 11974 CV-11974 CV11974 Candesartan (USAN/INN) Candesartan [BAN] Candesartan [USAN:INN] Candesartan cilexetil D00522 DB00796 FT-0083585 HMS2089M22 HSDB 7520 I01-0374 KS-5003 L000156 LS-32740 MolPort-003-845-570 MolPort-005-943-739 NCGC00167474-01 Ratacand S1578_Selleck TL8000897 UNII-S8Q36MD2XX candesartan |
| | 25 | | Calcium acetate | approved | Phase 4, Phase 3 | 20 | 62-54-4 | | Acetate OF lime Brown acetate of lime Ca(oac)2 | Gray acetate of lime Lime acetate Lime pyrolignite calcium ethanoate calcium(II) acetate |
| | 26 | | Insulin Lispro | approved | Phase 4 | 235 | 133107-64-9 | | Insulin lispro (genetical recombination) Insulin lispro (rDNA origin) Insulin lispro protamine | Insulin lispro protamine recombinant Insulin lispro recombinant Insulin,lispro,human/rDNA Insulin,lispro,protamine/rDNA | |
| | 27 | | Sevelamer | approved | Phase 4, Phase 3, Phase 2 | 74 | 52757-95-6, 152751-57-0 | 3085017 | | Sevelamero Sevelamerum Sévélamer |
| | 28 | | Spironolactone | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 222 | 1952-01-7, 52-01-7 | 5833 | 4-18-00-01601 (Beilstein Handbook Reference) 4-Pregnen-21-oic acid-17alpha-ol-3-one-7alpha-thiol gamma-lactone 7-acetate 496916-40-6 52-01-7 7-alpha-Acetylthio-3-oxo-17-alpha-pregn-4-ene-21,17-beta-carbolactone 7alpha-(acetylsulfanyl)-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone AB00513806 AC-4214 AC1L1L8Q Abbolactone Acelat Aldace Aldactazide Aldactide Aldactone Aldactone (TN) Aldactone A Alderon Aldopur Almatol Alphapharm Brand of Spironolactone Alpharma Brand of Spironolactone Alter Brand of Spironolactone Altex Aquareduct Ashbourne Brand of Spironolactone Azupharma Brand of Spironolactone BIDD:PXR0071 BPBio1_000194 BRD-K90027355-001-03-4 BRN 0057767 BSPBio_000176 C07310 C24H32O4S CHEBI:428201 CHEBI:45692 CHEBI:9241 CHEMBL1393 CID5833 CPD000471892 Cardel Brand of Spironolactone D00443 D013148 DB00421 Deverol Dexo Brand of Spironolactone Diatensec Dira Duraspiron EINECS 200-133-6 Espironolactona Espironolactona Alter Espironolactona Mundogen Espironolactona [INN-Spanish] Euteberol Flumach Frumikal Generosan Brand of Spironolactone HMS1568I18 HMS2090N21 HSDB 3184 Hormosan Brand of Spironolactone I06-1970 Jenapharm Brand of Spironolactone Jenaspiron LS-118614 LT00772287 Lacalmin Lacdene Laractone MLS001074672 MLS001333253 MLS001333254 MLS002153245 MLS002207058 Mayoly-Spindler Brand of Spironolactone Melarcon Merck dura Brand of Spironolactone Mundogen Brand of Spironolactone NCGC00164397-01 | NCGC00164397-02 NSC 150399 NSC150399 Nefurofan Novo Spiroton Novo-Spiroton NovoSpiroton Novopharm Brand of Spironolactone Osyrol Pfizer Brand of Spironolactone Pharmafrid Brand of Spironolactone Practon Prestwick0_000128 Prestwick1_000128 Prestwick2_000128 Prestwick3_000128 Roche Brand of Spironolactone S0260 S3378_SIGMA SAM002264648 SC 9420 SC-9420 SC9420 SMR000471892 SNL SPBio_002115 Sagisal Searle Brand of Spironolactone Sincomen Spiractin Spiresis Spiretic Spiridon Spiro L.U.T. Spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan) Spiro-Tablinen Spiro[17H-cyclopenta[a]phenauthrene-17,2'-(3'H)-furan] Spirobeta Spiroctan Spiroctanie Spiroderm Spirogamma Spirolactone Spirolakton Spirolang Spirolone Spirone Spirono Isis Spirono-Isis Spironocompren Spironolactone Spironolactone (JP15/USP/INN) Spironolactone A Spironolactone [BAN:INN:JAN] Spironolactone [INN:BAN:JAN] Spironolactonum Spironolactonum [INN-Latin] Spironolattone Spironolattone [DCIT] Spironone Spirospare Sprioderm Supra-puren Suracton UNII-27O7W4T232 Uractone Urusonin Veroshpiron Verospiron Verospirone Verospirone Opianin WLN: L E5 B666 FX OV MUTJ A1 E1 KSV1 F-& CT5VOXTJ Worwag Brand of Spironolactone Xenalon ZINC03861599 betapharm Brand of Spironolactone ct Arzneimittel Brand of Spironolactone ct-Arzneimittel Brand of Spironolactone spiro von ct spironolactone spironolattone von ct, spiro |
| | 29 | | Icodextrin | approved, investigational | Phase 4, Phase 3, Phase 2 | 37 | 337376-15-5 | | | Icodextrina Icodextrine Icodextrinum |
| | 30 | | Benzocaine | approved | Phase 4, Phase 3, Phase 2 | 1892 | 1994-09-7, 94-09-7 | 2337 | (p-(Ethoxycarbonyl)phenylamine 06952_FLUKA 112909_ALDRICH 112909_SIAL 1333-08-0 23239-88-5 23239-88-5 (hydrochloride) 4 Aminobenzoic Acid Ethyl Ester 4-(Ethoxycarbonyl)aniline 4-(Ethoxycarbonyl)phenylamine 4-14-00-01129 (Beilstein Handbook Reference) 4-Aminobenzoate 4-Aminobenzoic acid 4-Aminobenzoic acid ethyl ester 4-Aminobenzoic acid, ethyl ester 4-Carbethoxyaniline 4-amino-benzoic acid ethyl ester 4-aminobenzoic acid ethyl ester 71123-91-6 94-09-7 94-09-7 (Parent) A0271 AB00051923 AC1L1DGC AC1Q341A AC1Q64JE AE-562/40377256 AI3-02081 AKOS000119763 AR-1H9065 Acetate, Benzocaine Aethoform Aethylium paraminobenzoicum Amben ethyl ester Americaine Anaesthan-syngala Anaesthesin Anaesthesinum Anaesthin Anestezin Anestezin [Russian] Anesthesin Anesthesine Anesthone BB_SC-0019 BPBio1_001017 BRD-K75466013-001-05-2 BRN 0638434 BSPBio_000923 BSPBio_001908 Baby Anbesol Bensokain Benzoak Benzocaina Benzocaina [INN-Spanish] Benzocaine Benzocaine (USP/INN) Benzocaine Acetate Benzocaine Formate Benzocaine Hydrobromide Benzocaine Hydrochloride Benzocaine Methanesulfonate Benzocaine [INN:BAN] Benzocainum Benzocainum [INN-Latin] Benzoic acid, 4-amino-, ethyl ester Benzoic acid, 4-amino-, ethyl ester, hydrochloride Benzoic acid, amino-, ethyl ester Benzoic acid, p-amino-, ethyl ester C07527 CAS-94-09-7 CHEBI:116735 CHEMBL278172 CID2337 Caswell No. 430A Chloraseptic D001566 D00552 DB01086 Dermoplast Diet Ayds DivK1c_000932 E1501_SIGMA EINECS 202-303-5 EPA Pesticide Chemical Code 097001 ETHYL-P-AMINOBENZOATE Ethoform Ethoforme Ethyl 4-aminobenzoate Ethyl 4-aminobenzoate hydrochloride Ethyl 4-aminobenzoic acid Ethyl Aminobenzoate Ethyl PABA | Ethyl aminobenzoate Ethyl aminobenzoate (JP15) Ethyl aminobenzoate (VAN) Ethyl aminobenzoic acid Ethyl p-Aminobenzoate Ethyl p-Aminophenylcarboxylate Ethyl p-aminobenzenecarboxylate Ethyl p-aminobenzoate Ethyl p-aminobenzoic acid Ethyl p-aminophenylcarboxylate Ethylester kyseliny p-aminobenzoove Ethylester kyseliny p-aminobenzoove [Czech] Ethylis aminobenzoas Formate, Benzocaine HMS1570O05 HMS1920G09 HMS2091M11 HMS502O14 HSDB 7225 Hurricaine Hydrobromide, Benzocaine Hydrochloride, Benzocaine I05-0204 IDI1_000932 Identhesin KBio1_000932 KBio2_000474 KBio2_003042 KBio2_005610 KBio3_001408 KBioGR_000658 KBioSS_000474 Keloform LS-35847 MLS001331704 MLS002153970 Methanesulfonate, Benzocaine MolPort-000-871-526 NCGC00016352-01 NCGC00094598-01 NCGC00094598-02 NINDS_000932 NSC 122792 NSC 41531 NSC41531 NSC4688 Norcain Norcaine Norcainum Oprea1_750694 Oprea1_827402 Ora-jel Orabase-B Orthesin Otocain Outgro Parathesin Parathesin (TN) Parathesine Prestwick0_000712 Prestwick1_000712 Prestwick2_000712 Prestwick3_000712 Prestwick_991 SMR000059025 SPBio_000134 SPBio_002844 SPECTRUM1500139 STK043620 Slim Mint Gum Solarcaine Solu H Spectrum2_000117 Spectrum3_000314 Spectrum4_000249 Spectrum5_000860 Spectrum_000074 Topcaine UNII-U3RSY48JW5 WLN: ZR DVO2 ZINC12358719 benzocaine ethylaminobenzoate-4 h-4-abz-oet nchembio.182-comp4 p-(Ethoxycarbonyl)aniline p-Aminobenzoate p-Aminobenzoic acid p-Aminobenzoic acid ethyl ester p-Aminobenzoic acid, ethyl ester p-Aminobenzoic ethyl ester p-Carbethoxyaniline p-Ethoxycarboxylic Aniline p-Ethoxycarboxylic aniline | |
| | 31 | | Cyclosporine | approved, investigational, vet_approved | Phase 4, Phase 3, Phase 1, Phase 2 | 915 | 79217-60-0, 59865-13-3 | 5284373, 6435893 | 1c5f 1cyn 30024_FLUKA 30024_SIGMA 59865-13-3 79217-60-0 AC1L1EQW AC1NQXJE AC1NR4C4 AC1NUQK3 AC1NUZNC AC1O5KOG AC1Q2UDG Ambap59865-13-3 Ambotz59865-13-3 Antibiotic S 7481F1 BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA BPBio1_000496 BRD-A64290322-001-01-6 BRD-A69815203-001-04-3 BRD-K13533483-001-03-0 BSPBio_000450 BSPBio_001596 BSPBio_003186 C 3662 C05086 C1832_SIGMA C3662_SIGMA C62H111N11O12 CB-01-09 MMX CHEBI:106343 CHEBI:328305 CHEBI:4031 CHEMBL160 CHEMBL386389 CHEMBL532318 CID2909 CID5280754 CID5284373 CID5458585 CID5497195 CID6435893 CSA CYCLOSPORIN A (SEE ALSO TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A)) CYCLOSPORIN A, USP Ciclosporin Ciclosporin (JP15) Ciclosporina Ciclosporine Ciclosporinum Cipol N Cipol-N Consupren Consupren S CsA CsA & IFN.alpha. CyA Cyclokat Cyclosporin Cyclosporin A Cyclosporin A & IFN.alpha. Cyclosporin A Implant Cyclosporin A, Tolypocladium inflatum Cyclosporine (USP) Cyclosporine A Cyclosporine [USAN] D00184 DE-076 DivK1c_000871 EU-0100242 Equoral GNF-Pf-2808 Gengraf Gengraf (TN) HMS1569G12 HMS1791P18 HMS1921L20 HMS1989P18 HMS2089A09 HMS2092F06 HMS502L13 Helv Chim Acta 60: 1568 (1977) | I06-0379 I06-0966 IDI1_000871 KBio1_000871 KBio2_000780 KBio2_003348 KBio2_005916 KBio3_002686 KBioGR_001898 KBioSS_000780 LMPK14000003 LS-257 LS-58836 Lopac0_000242 MLS000028376 MLS001333756 MLS002153454 MLS002207033 Mitogard Modusik-A MolPort-000-760-988 MolPort-005-934-008 MolPort-006-705-994 NCGC00093704-01 NCGC00093704-02 NCGC00093704-03 NCGC00093704-04 NCGC00093704-05 NCGC00093704-06 NCGC00093704-07 NCGC00093704-08 NCGC00164258-01 NCGC00164258-02 NINDS_000871 NSC290193 Neoplanta Neoral Neoral (TN) NeuroSTAT Nova-22007 OL 27-400 OL-27400 OLO-400 Papilock Prestwick2_000435 Prestwick3_000435 Prestwick_731 Pulminiq Ramihyphin A Restasis Restasis (TN) S-Neoral S1514_Selleck SDZ-OXL 400 SMR000058578 SPBio_001467 SPECTRUM1502202 ST-603 Sandimmun Sandimmun Neoral Sandimmune Sandimmune (TN) Sandimmune, Gengraf, Restasis, Atopica, Sangcya, Cyclosporine Sang-2000 Sang-35 SangCyA Sangcya Sigmasporin Sigmasporin Microoral Spectrum2_001484 Spectrum3_001593 Spectrum4_001279 Spectrum5_001628 Spectrum_000300 TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A) Vekacia Zyclorin cyclophorine cyclosporin A cyclosporine from Tolypocladium inflatum (Trichoderma polysporin) nchembio.184-comp6 nchembio.301-comp5 nchembio.342-comp1 | |
| | 32 | | Digoxin | approved | Phase 4 | 135 | 20830-75-5 | 30322, 2724385 | (3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide 0B9662A7-264E-4ACD-94B2-9E1138C0CA5A 12beta-Hydroxydigitoxin 12β-hydroxydigitoxin 20830-75-5 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^ 4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one AC1MC4TN AC1Q29PT BIDD:PXR0148 BPBio1_000500 BRD-K23478508-001-03-7 BSPBio_000454 C06956 CHEBI:4551 CHEMBL1751 CID2724385 Cardoxin Cogoxin Cordioxil D00298 D1828 D6003_FLUKA D6003_SIGMA D6770_SIGMA Davoxin Digacin Digazolan Digitalis Glycoside Digitalis glycoside Digitekt Digossina Digoxin Digoxin (JP15/USP) Digoxin Pediatric Digoxina Digoxine Digoxinum Dilanacin Dixina Dokim | Dynamos Eudigox HMS1569G16 Homolle'S digitalin Homolle's Digitalin Lanacordin Lanacrist Lanadicor Lanicor Lanoxicaps Lanoxicaps (TN) Lanoxin Lanoxin (TN) Lenoxicaps Lenoxin Longdigox MLS000069819 MLS001055371 MLS001076495 MolPort-002-536-760 NCGC00090797-01 NCGC00090797-02 NCGC00090797-03 NCGC00090797-04 Neo-Lanicor Neodioxanin Prestwick0_000437 Prestwick1_000437 Prestwick2_000437 Prestwick3_000437 Prestwick_170 Rougoxin SK-Digoxin SMR000059217 SMR000653537 SPBio_002393 SR-01000721866-3 ST069334 STOCK1N-70146 Stillacor Vanoxin digoxin nchembio.476-comp8 | |
| | 33 | | Simvastatin | approved | Phase 4 | 510 | 79902-63-9 | 54454 | (+)-Simvastatin (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate 2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one 79902-63-9 AC-1530 AC1L1H1F AKOS005111006 ARONIS24119 BCBcMAP01_000007 BIDD:GT0769 BPBio1_001001 BRD-K22134346-001-05-8 BRN 4768037 BSPBio_000909 BSPBio_002337 Bio-0672 Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester C25H38O5 CCRIS 7558 CHEBI:9150 CHEMBL1064 CID54454 CPD000718785 Cholestat Coledis Colemin Corolin D00434 D019821 DRG-0320 Denan DivK1c_006991 Eucor HMS1570N11 HMS1922H13 HMS2089D12 HMS2093E06 HSDB 7208 InChI=1/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1 KBio1_001935 KBio2_002197 KBio2_004765 KBio2_007333 KBio3_001557 KBioGR_001244 KBioSS_002197 KS-1113 Kolestevan L 644128-000U LS-46264 Labistatin Lipex Lipinorm Liponorm Lipovas Lodales MK 0733 MK 733 MK-0733 MK-733 MK733 MLS001304029 MLS001333077 MLS001333078 | MLS002154038 Medipo Modutrol MolPort-002-507-345 MolPort-002-885-862 NCGC00017324-01 NCGC00017324-02 NCGC00017324-03 Nivelipol Nor-Vastina Pantok Pepstatin Prestwick0_000865 Prestwick1_000865 Prestwick2_000865 Prestwick3_000865 Prestwick_171 Rechol Rendapid S1792_Selleck S6196_SIGMA SAM002589969 SMR000718785 SPBio_001881 SPBio_002830 SPECTRUM1504236 STK801938 Simcor Simovil Simvast CR Simvastatin Simvastatin & Primycin Simvastatin (JAN/USP/INN) Simvastatin [USAN:INN:BAN] Simvastatin [Usan:Ban:Inn] Simvastatin lactone Simvastatin, Compactin Simvastatina Simvastatina [Spanish] Simvastatine Simvastatine [French] Simvastatinum Simvastatinum [Latin] Simvotin Sinvacor Sinvascor Sivastin SpecPlus_000895 Spectrum2_001671 Spectrum3_000669 Spectrum4_000632 Spectrum5_001428 Spectrum_001717 Statin Synvinolin TNP00259 UNII-AGG2FN16EV Valemia Vasotenal Velostatin Vytorin ZINC03780893 Zocor Zocor (TN) Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin Zocord [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta nchembio790-comp16 simvastatin |
| | 34 | | Rosiglitazone | approved, investigational | Phase 4, Phase 3 | 220 | 122320-73-4 | 77999 | (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion (±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione 122320-73-4 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- (9CI) 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione 5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate 5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione 5-[[4-[2-(methyl-(2-pyridyl)amino)ethoxy]phenyl]methyl] thiazolidine-2,4-dione 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione AC-3459 AC1L2U9N Avandia BRD-A97437073-001-02-3 BRD-A97437073-001-03-1 BRL49653 BSPBio_002693 Brl 49653 Brl-49653 C18H19N3O3S CID77999 D08491 DB00412 Gaudil Gaudil (TN) HMS1922J11 HMS2094O13 HSDB 7555 I06-0141 IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin) KBio2_002183 KBio2_004751 KBio2_007319 KBio3_001913 | KBioGR_001609 KBioSS_002183 LS-151340 MolPort-002-508-212 NCGC00095124-01 NCGC00095124-02 NCGC00095124-03 RGZ RSG Rosi Rosigilitazone Rosigliazone maleate Rosiglitazon Rosiglitazona Rosiglitazone Rosiglitazone (INN) Rosiglitazone [INN:BAN] Rosiglitazone maleate Rosiglitazonum Rosiglizole S00306 SPBio_001142 SPECTRUM1504263 STOCK6S-23924 Spectrum2_001241 Spectrum3_000997 Spectrum4_001125 Spectrum5_001464 Spectrum_001703 TDZ 01 UNII-05V02F2KDG [3H]rosiglitazone rosiglitazona rosiglitazone rosiglitazone (Avandia) rosiglitazonum |
| | 35 | | Methylprednisolone | approved, vet_approved | Phase 4, Phase 2, Phase 3, Phase 1 | 1153 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone |
| | 36 | | Daclizumab | approved, investigational | Phase 4, Phase 2 | 98 | 152923-56-3 | | Dacliximab Daclizumab beta | |
| | 37 | | Procaine | approved, investigational, vet_approved | Phase 4 | 48 | 59-46-1 | 4914 | .beta.-(Diethylamino)ethyl p-aminobenzoate .beta.-Diethylaminoethyl 4-aminobenzoate 2-(Diethylamino)ethyl 4-aminobenzoate 2-(Diethylamino)ethyl p-aminobenzoate 2-(Diethylamino)ethyl-4-aminobenzoate 2-Diethylaminoethyl 4-aminobenzoate 2-Diethylaminoethyl p-aminobenzoate 2-Diethylaminoethylester kyseliny p-aminobenzoove 2-Diethylaminoethylester kyseliny p-aminobenzoove [Czech] 4-14-00-01138 (Beilstein Handbook Reference) 4-Aminobenzoesaeure-beta-diethylaminoethylester 4-Aminobenzoic acid 2-(diethylamino) ethyl ester 4-Aminobenzoic acid diethylaminoethyl ester 4-aminobenzoic acid 2-diethylaminoethyl ester 59-46-1 91484-72-9 AB00053531 AC1L1J8C AC1Q2ZE2 AKOS000115407 Allocaine Anticort Anticort (TM) Anuject BENZOIC ACID,4-AMINO,2-DIETHYLAMINOETHYL ESTER PROCAIN BASE BPBio1_000179 BRD-K24616672-003-05-2 BRN 0913480 BSPBio_000161 BSPBio_002231 Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester Benzoic acid, p-amino-, 2-(diethylamino)ethyl ester C07375 CAS-51-05-8 CHEBI:8430 CHEMBL569 CID4914 D08422 DB00721 Diethylaminoethyl p-aminobenzoate DivK1c_000120 Duracaine EINECS 200-426-9 Factor H3 Gerokit Gerovital Gerovital H-3 HSDB 3388 I06-1439 IDI1_000120 InChI=1/C13H20N2O2/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H Jenacain Jenacaine KBio1_000120 KBio2_001318 KBio2_003886 KBio2_006454 KBio3_001731 | KBioGR_000975 KBioSS_001318 LS-35778 Lopac-P-9879 Lopac0_000966 MolPort-000-889-177 NCGC00015864-01 NCGC00015864-02 NCGC00015864-04 NCGC00162298-01 NINDS_000120 NSC 169497 NSC169497 Nissocaine Norocaine Novocain Novocaine Prestwick0_000041 Prestwick1_000041 Prestwick2_000041 Prestwick3_000041 Procain Procaina Procaina [INN-Spanish] Procaine (INN) Procaine HCl Procaine [INN:BAN] Procaine, base Procainum Procainum [INN-Latin] SP-01A SP01 SP01A SPBio_001331 SPBio_002082 STK177303 STOCK2S-12721 Scurocaine Solution of novocain Solution of novocain (TN) Spectrum2_001296 Spectrum3_000556 Spectrum4_000488 Spectrum5_001186 Spectrum_000838 Spinocaine Stoff H3 UNII-4Z8Y51M438 Vitamin H3 WLN: ZR DVO2N2&2 beta-(Diethylamino)ethyl 4-aminobenzoate beta-(Diethylamino)ethyl p-aminobenzoate beta-Diethylaminoethyl 4-aminobenzoate p-Aminobenzoic acid 2-diethylaminoethyl ester p-Aminobenzoyldiethylaminoethanol p-Aminobenzyoyldiethylaminoethanol procaine β-(diethylamino)ethyl 4-aminobenzoate β-(diethylamino)ethyl p-aminobenzoate | |
| | 38 | | Menthol | approved | Phase 4, Phase 3, Phase 2 | 2353 | 2216-51-5 | 16666 | (− ()-Menthol (+)-Neo-menthol (+)-p-Menthan-3-ol (+-)-(1R*,3R*,4S*)-Menthol (+-)-Menthol (+/-)-Menthol (+/-)-p-Menthan-3-ol (-)-(1R,3R,4S)-Menthol (-)-Menthyl alcohol (-)-menthol (-)-p-Menthan-3-ol (-)-trans-p-Menthan-cis-ol (1R)-(-)-Menthol (1R,2S,5R)-(-)-menthol (1R,2S,5R)-Menthol (1R,3R,4S)-(-)-MENTHOL (1R,3R,4S)-(-)-Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol (1S, 2S, 5R)-(+)-Neomenthol (1S,2R,5R)-(+)-Isomenthol (1S,2R,5S)-(+)-Menthol (1S,2R,5S)-Menthol (1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol (1r,2s,5r)-(-)-menthol (L)-MENTHOL (R)-(-)-Menthol (r)-(-)-menthol )-Menthol --MENTHOL 1-Menthol 1490-04-6 15356-60-2 15356-70-4 15785_RIEDEL 15785_SIAL 19863P 2-Isopropyl-5-methylcyclohexanol 20747-49-3 2216-51-5 3-p-Menthol 4-Isopropyl-1-methylcyclohexan-3-ol 491-02-1 5-Methyl-2-(1-methylethyl)-cyclohexanol 5-Methyl-2-(1-methylethyl)cyclohexanol 5-methyl-2-(propan-2-yl)cyclohexanol 5-methyl-2-propan-2-ylcyclohexan-1-ol 551376_ALDRICH 551376_FLUKA 588733_ALDRICH 613290_ALDRICH 613290_FLUKA 63660_FLUKA 63670_ALDRICH 63670_FLUKA 63975-60-0 6C6A4A8C-A054-468C-A1F0-F29E39838CF2 89-78-1 98167-53-4 AC1L1B2E AC1L28FR AC1Q1NQ2 AC1Q2QQM AI3-08161 AI3-52408 AKOS000119740 AR-1J3337 BB_NC-0057 BRN 1902288 BRN 3194263 BSPBio_003062 C00400 C10H20O CCRIS 3728 CCRIS 375 CCRIS 4666 CCRIS 9231 CHEBI:15409 CHEBI:545611 CHEMBL256087 CHEMBL470670 CID1254 CID16666 Caswell No. 540 D-(-)-Menthol D-p-Menthan-3-ol D00064 D008610 D04849 D04918 DB00825 DivK1c_000820 EINECS 201-939-0 EINECS 207-724-8 EINECS 216-074-4 EINECS 218-690-9 EINECS 239-387-8 EINECS 239-388-3 EPA Pesticide Chemical Code 051601 FEMA No. 2665 Fisherman's friend lozenges Fisherman's friend lozenges (TN) HMS1922G13 HMS2092L14 HMS502I22 | HSDB 5662 HSDB 593 Headache crystals Hexahydrothymol I06-1216 I14-7371 IDI1_000820 KBio1_000820 KBio2_000785 KBio2_003353 KBio2_005921 KBio3_002562 KBioSS_000785 L-(-)-Menthol L-(-)-menthol L-Menthol L-menthol LMPR0102090001 LS-2353 LS-57201 LS-886 LS-89531 LS-89533 Levomenthol Levomenthol [INN:BAN] Levomentholum Levomentholum [INN-Latin] Levomentol M0321 M0545 M2772_SIAL MENTHOL MLS002207256 Menthacamphor Menthol Menthol (USP) Menthol (VAN) Menthol natural Menthol natural, brazilian Menthol racemic Menthol racemique Menthol racemique [French] Menthol solution Menthol, (1alpha,2beta,5alpha)-Isomer Menthomenthol Menthyl alcohol MolPort-000-849-729 MolPort-001-793-392 NCGC00159382-02 NCGC00159382-03 NCGC00164247-01 NCGC00164247-02 NCI-C50000 NINDS_000820 NOOLISFMXDJSKH-KXUCPTDWBX NSC 2603 NSC 62788 NSC2603 NSC62788 Neoisomenthol Peppermint camphor RACEMIC MENTHOL U.S.P. Racementhol Racementhol [INN:BAN] Racementholum Racementholum [INN-Latin] Racementol Racementol [INN-Spanish] Racemic menthol Robitussin Cough Drops SDCCGMLS-0066659.P001 SMR001306785 SPBio_000869 SPECTRUM1503134 STK802468 Spectrum2_000855 Spectrum3_001561 Spectrum5_001060 Spectrum_000305 Tra-kill tracheal mite killer U.S.P. Menthol U.S.p. Menthol UNII-BZ1R15MTK7 UNII-L7T10EIP3A UNII-YS08XHA860 W266507_ALDRICH W266523_ALDRICH W266590_ALDRICH WLN: L6TJ AY1&1 BQ D1 WLN: L6TJ AY1&1 DQ D1 -L ZINC01482164 cis-1 ,3-trans-1,4-(+-)-menthol cis-1,3-trans-1,4-(+-)-menthol d,l-Menthol d-Menthol d-Neomenthol dl-3-p-Menthanol dl-Menthol dl-Menthol (JP15) l-(-)-Menthol l-Menthol l-Menthol (JP15) l-Menthol (TN) l-Menthol (natural) nchembio862-comp1 p-Menthan-3-ol rac-Menthol |
| | 39 | | Nitric Oxide | approved | Phase 4, Phase 3, Phase 1, Phase 2 | 599 | 10102-43-9 | 145068 | (.)NO (NO)(.) 10102-43-9 14332-28-6 295566_ALDRICH 51005-20-0 51005-21-1 53851-19-7 90452-29-2 AC1L1ADQ AC1L3QHF AC1Q6QZ0 AR-1K7463 Bioxyde d'azote Bioxyde d'azote [French] C00533 CCRIS 4319 CHEMBL1200689 CHEMBL1234765 CID145068 CID945 D00074 D009569 DB00435 EDRF EINECS 233-271-0 Endogenous Nitrate Vasodilator Endothelium-Derived Nitric Oxide HNO HSDB 1246 INOmax INOmax (TN) LS-192158 LS-7547 MolPort-003-929-452 Mononitrogen monoxide Monoxide, Mononitrogen Monoxide, Nitrogen Monoxido de nitrogeno Monoxyde d'azote NITRIC-OXIDE NO NO(.) Nitrate Vasodilator, Endogenous Nitric Oxide, Endothelium Derived | Nitric Oxide, Endothelium-Derived Nitric oxide Nitric oxide (JAN) Nitric oxide 10% by volume or more Nitric oxide trimer Nitric oxide, compressed [UN1660] [Poison gas] Nitric oxide, compressed [UN1660] [Poison gas] Nitrogen monoxide Nitrogen oxide Nitrogen oxide (NO) Nitrogen protoxide Nitrosyl Nitrosyl hydride Nitrosyl hydride ((NO)H) Nitrosyl radical Nitroxide radical Nitroxyl OHM 11771 Oxide, Nitric Oxido de nitrogeno(ii) Oxido nitrico Oxyde azotique Oxyde nitrique Oxyde nitrique [French] RCRA waste no. P076 Stickmonoxyd Stickmonoxyd [German] Stickstoff(II)-oxid Stickstoff(ii)-oxid Stickstoffmonoxid UN 1660 UN1660 UNII-31C4KY9ESH Vasodilator, Endogenous Nitrate [NO] endothelium-derived relaxing factor monoxido de nitrogeno monoxyde d'azote nitric oxide nitrogen monooxide nitrogen monoxide nitrosyl oxido de nitrogeno(II) oxido nitrico oxidonitrogen(.) oxoazanyl oxyde azotique |
| | 40 | | Prednisolone | approved, vet_approved | Phase 4, Phase 2, Phase 3, Phase 1 | 1153 | 50-24-8 | 5755 | (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione .DELTA.1-Cortisol .DELTA.1-Dehydrocortisol .DELTA.1-Dehydrohydrocortisone .DELTA.1-Hydrocortisone .delta.-Cortef .delta.-Stab 1,2-Dehydrohydrocortisone 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol 1-Dehydrocortisol 1-Dehydrohydrocortisone 3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene 46656_FLUKA 46656_RIEDEL 50-24-8 58201-11-9 8056-11-9 AC-1773 AC1L1L2E Ak-Pred Ak-Tate Alphadrol Articulose-50 BPBio1_000164 BRD-K98039984-001-03-0 BRN 1354103 BSPBio_000148 Bio-0666 Bubbli-Pred C07369 CCRIS 980 CHEBI:8378 CHEMBL131 CID5755 CO-Hydeltra CPD000718761 Co-Hydeltra Codelcortone Cordrol Cortalone Cotogesic Cotolone D00472 D011239 DB00860 Decaprednil Decortin H Delcortol Delta F Delta(1)-dehydrohydrocortisone Delta-Cortef Delta-Cortef (TN) Delta-Ef-Cortelan Delta-Stab Delta-stab Deltacortenol Deltacortril Deltacortril Enteric Deltahydrocortisone Deltasolone Deltisilone Depo-Medrol Derpo PD Derpo Pd Dexa-Cortidelt Hostacortin H Dexa-Cortidelt hostacortin H Di Adreson F Di-Adreson F Di-Adreson-F Di-adreson F DiAdresonF Dicortol Donisolone Dydeltrone EINECS 200-021-7 Eazolin D Econopred Econopred Plus Erbacort Erbasona Estilsona Fernisolone Fernisolone P Fernisolone-P Flamasone HMS1568H10 HMS2090J05 HSDB 3385 Hostacortin H Hydeltra Hydeltra-Tba Hydeltrasol Hydeltrone Hydrodeltalone Hydrodeltisone Hydroretrocortin Hydroretrocortine I-Pred Inflamase Forte Inflamase Mild K 1557 Key-Pred Klismacort LMST02030179 LS-7669 Lentosone Lite Pred M-Predrol | MLS001304083 MLS002154250 MLS002207037 Medrol Medrol Acetate Metacortandralone Methylprednisolone Acetate Meti-Derm Meticortelone Metreton MolPort-002-507-147 NCGC00179649-01 NSC 9120 NSC9120 NSC9900 Neo-Delta-Cortef Nisolone Nor-Pred T.B.A. Ocu-Pred Ocu-Pred Forte Ophtho-Tate Orapred P0152_SIGMA P0637 P6004_SIGMA PRDL PRED-G Panafcortelone Paracortol Paracotol Pediapred Poly-Pred Precortalon Precortancyl Precortilon Precortisyl Pred Forte Pred Mild Predair Predair A Predair Forte Predalone 50 Predalone T.B.A. Predate Predate Tba Predate-50 Predcor-25 Predcor-50 Predcor-Tba Predisolone Sodium Phosphate Predne-Dome Prednelan Predni-Dome Prednicen Predniliderm Predniretard Prednis Prednisolona Prednisolona [INN-Spanish] Prednisolone (JP15/USP/INN) Prednisolone (anhydrous) Prednisolone Acetate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisolone [INN:BAN:JAN] Prednisolonum Prednisolonum [INN-Latin] Predonin Predonine Prelone Prenolone Prestwick0_000274 Prestwick1_000274 Prestwick2_000274 Prestwick3_000274 Prestwick_404 Rolisone S1737_Selleck SAM002264639 SMR000718761 SPBio_002367 Scherisolon Solone Steran Sterane Sterolone Supercortisol UNII-9PHQ9Y1OLM Ulacort Ultra Pred Ultracorten H Ultracortene H Ultracortene-H Ultracortene-Hydrogen Ultracortene-hydrogen ZINC03833821 component of Ataraxoid component of K-Predne-Dome delta(1)-Cortisol delta(1)-Dehydrocortisol delta(1)-Dehydrohydrocortisone delta(1)-Hydrocortisone delta(sup 1)-Cortisol delta(sup 1)-Dehydrocortisol delta(sup 1)-Dehydrohydrocortisone delta(sup 1)-Hydrocortisone delta-dehydrocortisol delta-dehydrohydrocortisone delta-hydrocortisone prednisolone | |
| | 41 | | Pancrelipase | approved | Phase 4, Phase 3 | 935 | 53608-75-6 | | 1,4-alpha-D- glucan glucanohydrolase PA | Pancreatic alpha-amylase precursor Pancrelipase (amylase lipase protease) |
| | 42 | | Peginterferon alfa-2b | approved | Phase 4, Phase 2, Phase 1 | 308 | 99210-65-8, 215647-85-1 | | 215647-85-1 D02748 PEG-Intron PegIntron | Peginterferon alfa-2b Peginterferon alfa-2b (INN) Peginterferon alfa-2b (generical recombination) Peginterferon alfa-2b (generical recombination) (JAN) Pegintron (TN) Unitron PEG |
| | 43 | | Ribavirin | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 984 | 36791-04-5 | 37542 | 1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide 36791-04-5 437710-49-1 66510-90-5 AA-504/07617051 AB00430481 AC1L1XXZ AC1Q1IDC AC1Q4ZGS AKOS001715163 BB_NC-0567 BPBio1_001195 BRN 0892462 BSPBio_001085 BSPBio_003352 C-Virin CHEMBL1643 CID37542 Copegus Copegus (TN) Cotronak D00423 DB00811 DRG-0028 DivK1c_000782 Drug: Ribavirin EU-0101063 FT-0082885 HMS2090L15 HMS2094O09 HMS502H04 HSDB 6513 ICN-1229 IDI1_000782 KBio1_000782 KBio2_002328 KBio2_004896 KBio2_007464 KBio3_002854 KBioGR_001804 KBioSS_002331 KS-1104 LS-1241 Lopac0_001063 MLS000028486 MLS002222317 MolPort-002-507-104 MolPort-002-885-856 NCGC00090726-01 NCGC00090726-03 NCGC00090726-04 NCGC00090726-05 NCGC00090726-06 NCGC00090726-07 NINDS_000782 NSC 163039 | NSC163039 Prestwick3_000993 R 9644 R-964 R9644_SIGMA RBV RG-964 RIBAV RTC RTCA RTP Ravanex Rebetol Rebetol (TN) Rebetron Rebretron Ribacine Ribamide Ribamidil Ribamidyl Ribasphere Ribasphere (TN) Ribav Ribavirin Ribavirin (JAN/USP/INN) Ribavirin Capsules Ribavirin Triphosphate Ribavirin [USAN:INN] Ribavirin-TP Ribavirina Ribavirina [INN-Spanish] Ribavirine Ribavirine [INN-French] Ribavirinum Ribavirinum [INN-Latin] Ribovirin Ro 20-9963/000 Ro-20-9963 S2504_Selleck SCH 18908 SMP1_000261 SMR000058315 SPECTRUM1503938 SR-01000076112-3 Spectrum3_001876 Spectrum4_001252 Spectrum5_002075 Spectrum_001826 Tribavirin UNII-49717AWG6K Varazid Vilona Viramid Viramide Virazid Virazide Virazole Virazole (Ribavirin) Inhalation Solution Virazole (TN) Virazole 5'-triphosphate ZINC01035331 ribavirin | |
| | 44 | | Mycophenolic acid | approved | Phase 4, Phase 2, Phase 3, Phase 1 | 939 | 24280-93-1 | 446541 | (e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid Acide mycophenolique Acido micofenolico Acidum mycophenolicum | Melbex Micofenolico acido Mycophenoic acid Mycophenolate Mycophenolsäure Myfortic |
| | 45 | | Ezetimibe | approved | Phase 4 | 272 | 163222-33-1 | 150311 | (-)-Sch 58235 (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone) (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one (3R,4S)-1-(p-Fluorophenyl)-3-((3S)-3-(p-fluorophenyl)-3-hydroxypropyl)-4-(p-hydroxyphenyl)-2-azetidinone 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-(4-hydroxyphenyl)-2-azetidione 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone 163222-33-1 AC-1057 AC1L442L C108606 CHEBI:49040 CHEMBL1138 CID150311 CPD000466334 D01966 DB00973 Essex brand of ezetimibe Ezedoc Ezetimiba Ezetimibe Ezetimibe (JAN/USAN/INN) Ezetimibe [USAN:INN] Ezetimibum | Ezetrol HMS2051K16 LS-181801 MK-0653 MLS000759443 MLS001424125 MSD brand of ezetimibe Merck brand of ezetimibe MolPort-005-938-627 S1655_Selleck SAM001246623 SCH-58235 SCH58235 SMR000466334 STK640490 STOCK6S-73750 Sch 58235 Schering-Plough brand of ezetimibe UNII-EOR26LQQ24 ZINC03810860 Zetia Zetia (TN) Zetia , Ezetrol, Ezetimibe Zient ezetimib |
| | 46 | | Prednisone | approved, vet_approved | Phase 4, Phase 2, Phase 3, Phase 1 | 1359 | 53-03-2 | 5865 | (1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione .delta. E .delta.(sup1)-Cortisone .delta.-Cortelan .delta.-Cortisone .delta.-Cortone .delta.-E .delta.1-Cortisone .delta.1-Dehydrocortisone .delta.sone 1,2-Dehydrocortisone 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione 1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione 1-Cortisone 1-Dehydrocortisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione 17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione 53-03-2 68-59-7 81552_FLUKA AC-11112 AC1L1LB2 AC1Q29EZ ACon0_000082 ACon1_000297 AI3-52939 Adasone Ancortone Apo-Prednisone Apo-prednisone BPBio1_000323 BRD-K85883481-001-04-2 BSPBio_000293 Betapar Bicortone Bio-0649 C07370 C21H26O5 CCRIS 2646 CHEBI:8382 CHEMBL635 CID5865 CPD001227202 Cartancyl Colisone Cortan Cortancyl Cortidelt Cotone DB00635 Dacorten Dacortin Decortancyl Decortin Decortisyl Dehydrocortisone Dekortin Delcortin Dellacort Dellacort A Delta Cortelan Delta E Delta E. Delta-Cortelan Delta-Dome Delta-cortelan Delta-cortisone Delta-cortone Delta-dome Deltacortene Deltacortisone Deltacortone Deltasone Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone Deltison Deltisona Deltisone Deltra Di-Adreson Diadreson EINECS 200-160-3 Econosone Encorton Encortone Enkortolon Enkorton Fernisone Fiasone HMS1568O15 HMS2090J13 HSDB 3168 Hostacortin In-Sone Incocortyl | Juvason Kortancyl LMST02030180 LS-1325 Liquid Pred Lisacort Lodotra MEGxm0_000443 MLS001061265 MLS001304073 MLS001335907 MLS001335908 MLS002154191 MLS002207083 Me-Korti Metacortandracin Meticorten Meticorten (Veterinary) Metrevet (Veterinary) MolPort-001-740-041 NCGC00090766-01 NCGC00090766-02 NCGC00090766-03 NCI-C04897 NCI60_000008 NSC 10023 NSC10023 Nisona Nizon Novoprednisone Nurison Orasone Origen Prednisone P1276 P6254_SIGMA PRD Panafcort Panasol Paracort Parmenison Pehacort Precort Predeltin Prednicen-M Prednicorm Prednicort Prednicot Prednidib Prednilonga Prednison Prednisona Prednisona [INN-Spanish] Prednisone Prednisone Intensol Prednisone [INN:BAN] Prednisonum Prednisonum [INN-Latin] Prednitone Prednizon Prednovister Presone Prestwick0_000077 Prestwick1_000077 Prestwick2_000077 Prestwick3_000077 Prestwick_405 Pronison Pronisone Rectodelt Retrocortine S1622_Selleck SAM002264641 SK-Prednisone SMR000718760 SMR001227202 SPBio_002214 Servisone Sone Sterapred Supercortil U 6020 UNII-VB0R961HZT Ultracorten Ultracortene WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ Winpred Wojtab ZINC03875357 Zenadrid Zenadrid (veterinary) Zenadrid [veterinary] delta cortelan delta(sup 1)-Cortisone delta(sup 1)-Dehydrocortisone delta-1-Cortisone delta-1-Dehydrocortisone delta-Cortisone delta-Cortone | |
| | 47 | | Dalteparin | approved | Phase 4, Phase 2, Phase 3 | 303 | 9041-08-1 | | Daltepariininatrium Dalteparin Sodyum Dalteparin sodium Dalteparin sodná sůl Dalteparin-nátrium Dalteparina sódica | Dalteparinnatrium Dalteparino natrio druska Dalteparinum Natricum Dalteparyna sodowa Daltéparine sodique Heparin Fragment KABI 2165 Tedelparin | |
| | 48 | | Tamsulosin | approved, investigational | Phase 4 | 157 | 106133-20-4 | 129211 | (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide 106133-20-4 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide 5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide 5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide 5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide 5-[2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide 5-{(2R)-2-[(2-{[2-(ethyloxy)phenyl]oxy}ethyl)amino]propyl}-2-(methyloxy)benzenesulfonamide AC1L2V76 BIDD:GT0261 C07124 C20H28N2O5S CHEBI:9398 CHEMBL836 CID129211 D08560 DB00706 FT-0082894 Flomax Flomax (TN) | Flowmax HMS2090P15 Harnal LS-31578 MolPort-003-850-388 NCGC00167442-01 STK626950 TAMSULOSIN Tamsolusin Tamsulon Tamsulon (TN) Tamsulosin Tamsulosin (INN) Tamsulosin [INN:BAN] Tamsulosina Tamsulosina [INN-Spanish] Tamsulosine Tamsulosine [INN-French] Tamsulosinum Tamsulosinum [INN-Latin] UNII-G3P28OML5I YM-617 |
| | 49 | | Heparin | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 812 | 9005-49-6 | 772, 46507594 | 101921-26-0 102-94-3 102785-31-9 104521-37-1 11078-24-3 11129-39-8 12656-11-0 2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose 37324-73-5 6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid 9041-08-1 9045-22-1 9075-96-1 913079-23-9 91449-79-5 AC1L19ZN AC1L1ROY ALFA 87-120 ALFA 87-163 ALFA 87-198 ALFA 87-81 ALFA 88-247 AR-1E4539 Allocinnamic acid Ardeparin Ardeparin sodium Arteven Bemiparin Bemiparin sodium CID772 CID8784 CY 216 Calciparine Certoparin Clexane Clivarin Clivarine Cy 222 D006495 D017984 DB00407 DB01225 Dalteparin Dalteparin sodium Depo-Heparin EINECS 232-681-7 EMT 966 EMT 967 EMT-966 EMT-967 EMT966 EMT967 Enoxaparin Enoxaparin sodium Enoxaparine Eparina Eparina [DCIT] FR 860 Fluxum Fragmin A Fragmin B Fragmin IV Fraxiparin H 2149 HSDB 3094 Hed-heparin Hep Flush Kit in plastic container Hep-Lock Hep-Lock U/P Hep-lock Heparin Heparin CY 216 Heparin Lock Flush Heparin Lock Flush in plastic container Heparin Lock Flush preservative free Heparin Lock Flush preservative free in plastic container Heparin Sodium Heparin natrium Heparin sodium Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container Heparin sodium 1,000 units in dextrose 5% in plastic container Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container Heparin sodium 10,000 units in dextrose 5% Heparin sodium 10,000 units in dextrose 5% in plastic container Heparin sodium 10,000 units in sodium chloride 0.45% Heparin sodium 10,000 units in sodium chloride 0.9% Heparin sodium 12,500 units in dextrose 5% Heparin sodium 12,500 units in dextrose 5% in plastic container Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container Heparin sodium 12,500 units in sodium chloride 0.9% Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container Heparin sodium 2,000 units in dextrose 5% in plastic container Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container Heparin sodium 20,000 units and dextrose 5% in plastic container Heparin sodium 20,000 units in dextrose 5% in plastic container Heparin sodium 25,000 units and dextrose 5% in plastic container | Heparin sodium 25,000 units in dextrose 5% Heparin sodium 25,000 units in dextrose 5% in plastic container Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container Heparin sodium 25,000 units in sodium chloride 0.9% Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container Heparin sodium 5,000 units in dextrose 5% in plastic container Heparin sodium 5,000 units in sodium chloride 0.45% Heparin sodium 5,000 units in sodium chloride 0.9% Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container Heparin sodium in plastic container Heparin sodium preservative Free Heparin sulfate Heparin sulphate Heparin, Low Molecular Weight Heparin, Low-Molecular-Weight Heparin, sodium salt Heparina Heparina [INN-Spanish] Heparinate Heparine Heparine [INN-French] Heparinic acid Heparinsodiumsalt Heparinum Heparinum [INN-Latin] Heparinum natricum Hepathrom Hepflush-10 Inno-Hep Innohep Isocinnamic acid KB 101 Kabi 2165 LHN 1 LMWH Lioton 1000 Lipo-hepin Liquaemin Liquaemin Lock Flush Liquaemin Sodium Liquaemin sodium preservative free Liquemin Logiparin Lovenox Lovenox HP Low Molecular Weight Heparin Low molecular weight heparin Low molecular weight heparin sodium Low-Molecular-Weight Heparin Minolteparin sodium MolPort-003-760-257 Multiparin NSC174025 Nadroparin Nadroparine Novoheparin OP 386 OP 622 Octaparin PK 10,169 PK-10,169 PK-10169 PK10,169 PK10169 Pabyrin Panheprin Parnaparin Parnaparin sodium Parvoparin Pularin Reviparin Reviparin sodium Ro 11 Sandoparin Sodium acid heparin Sodium heparin Sodium heparinate Subeparin Sublingula Thromboliquine Tinzaparin Tinzaparin sodium Triofiban UNII-12M44VTJ7B UNII-3S182ET3UA UNII-E47C0NF7LV UNII-T2410KM04A UNII-ZZ45AB24CA Unfractionated heparin Vetren Vitrum AB WY 90493RD alpha-Heparin cis-.beta.-Carboxystyrene cis-Cinnamic acid enoxaparin heparin |
| | 50 | | Baclofen | approved | Phase 4 | 95 | 1134-47-0 | 2284 | ( inverted question mark)-Baclofen (+-)-Baclofen (+/-)- beta-(Aminoethyl)-4- chlorobenzenepropanoic acid (+/-)-BACLOFEN (+/-)-beta-(Aminomethyl)-4-chlorobenzenepropanoic acid (?)-Baclofen 1134-47-0 4-Amino-3-(4-chlorophenyl)butanoic acid 4-Amino-3-(4-chlorophenyl)butyric acid 62594-36-9 AB00051921 AC-4530 AC1L1DC6 ASTA Medica Brand of Baclofen AWD, Baclofen Alphapharm Brand of Baclofen Apo Baclofen Apo-Baclofen ApoBaclofen Apotex Brand of Baclofen Ashbourne Brand of Baclofen Athena Brand of Baclofen Atrofen B 5399 B3343 B5399_SIGMA BPBio1_000012 BPBio1_000750 BRD-A84174873-001-05-2 BRN 2104494 BSPBio_000010 BSPBio_001880 Ba 34647 Ba-34,647 Ba-34647 Ba34,647 Ba34647 Baclofen (JP15/USP/INN) Baclofen (R,S) Baclofen AWD Baclofen Alphapharm Brand Baclofen Apotex Brand Baclofen Ashbourne Brand Baclofen Athena Brand Baclofen Ciba-Geigy Brand Baclofen Irex Brand Baclofen Isis Brand Baclofen Medtronic Brand Baclofen Novartis Brand Baclofen Nu-Pharm Brand Baclofen Pharmascience Brand Baclofen [USAN:INN:BAN:JAN] Baclofene Baclofene Irex Baclofene [INN-French] Baclofene-Irex BaclofeneIrex Baclofeno Baclofeno [INN-Spanish] Baclofenum Baclofenum [INN-Latin] Baclon Baclophen Baclospas Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-(9CI) Biomol-NT_000251 C 34647Ba C10H12ClNO2 CCRIS 3722 CHEBI:2972 CHEMBL701 CIBA-34,647-BA CIBA34,647BA CID2284 Chlorophenyl GABA Ciba 34,647-Ba Ciba Geigy Brand of Baclofen Ciba-Geigy Brand of Baclofen Clofen D001418 D00241 DB00181 DL-4-Amino-3-P-chlorophenylbutanoic acid DL-4-Amino-3-p-chlorophenylbutanoic acid DL-Baclofen | DivK1c_000001 EINECS 214-486-9 EU-0100163 GABA, Chlorophenyl Gabalon Gen Baclofen Gen-Baclofen GenBaclofen Genpharm HMS1568A12 HMS1920E21 HMS2091M03 HMS500A03 I01-1934 IDI1_000001 Irex Brand of Baclofen Isis Brand of Baclofen KBio1_000001 KBio2_000466 KBio2_003034 KBio2_005602 KBio3_001380 KBioGR_000650 KBioSS_000466 Kemstro Kemstro (TN) L000002 LS-77134 Lebic Lioresal Lioresal (TN) Lioresal Intrathecal Lopac0_000163 MLS000028480 Medtronic Brand of Baclofen MolPort-002-051-370 NCGC00015156-05 NCGC00015156-12 NCGC00023843-03 NCGC00024579-03 NCGC00024579-04 NCGC00024579-05 NCGC00024579-06 NINDS_000001 NSC329137 Novartis Brand of Baclofen Nu Baclo Nu Pharm Brand of Baclofen Nu-Baclo Nu-Baclofen Nu-Pharm Brand of Baclofen NuBaclo Oprea1_440627 PCP-GABA PMS Baclofen PMSBaclofen Pharmascience Brand of Baclofen Pms-Baclofen Prestwick0_000085 Prestwick1_000085 Prestwick2_000085 Prestwick3_000085 Prestwick_85 SMP1_000036 SMR000058294 SPBio_000044 SPBio_001949 SPECTRUM1500135 STK535284 STOCK2S-30552 Spectrum2_000092 Spectrum3_000310 Spectrum4_000245 Spectrum5_000852 Spectrum_000066 UNII-H789N3FKE8 UPCMLD-DP142 UPCMLD-DP142:001 baclofen beta-(4-Chlorophenyl)gaba beta-(Aminomethyl)-4-chlorobenzenepropanoic acid beta-(Aminomethyl)-P-chlorohydrocinnamic acid beta-(Aminomethyl)-p-chlorohydrocinnamic acid beta-(P-Chlorophenyl)-gamma-aminobutyric acid beta-(p-Chlorophenyl)-gamma-aminobutyric acid gamma-Amino-beta-(P-chlorophenyl)butyric acid gamma-Amino-beta-(p-chlorophenyl)butyric acid |
|
Interventional clinical trials: (show top 50)
(show all 2123)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Qutenza for Critical Ischaemia in End Stage Renal Failure | Unknown status | NCT01704339 | Phase 4 | | 2 | Inspiratory Muscle Training in Patients With End Stage Renal Failure | Unknown status | NCT01347775 | Phase 4 | | 3 | Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis | Unknown status | NCT00291863 | Phase 4 | | 4 | Far Infrared Therapy on AV Fistula Flow, Endothelial Function and Echocardiography in ESRD Patients | Unknown status | NCT01138254 | Phase 4 | | 5 | A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD) | Unknown status | NCT01731301 | Phase 4 | | 6 | Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease | Unknown status | NCT00852787 | Phase 4 | | 7 | Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients | Unknown status | NCT01198379 | Phase 4 | | 8 | Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure | Unknown status | NCT00716573 | Phase 4 | | 9 | Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure | Unknown status | NCT00716001 | Phase 4 | | 10 | NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED | Unknown status | NCT00501475 | Phase 4 | | 11 | Effects of On-Line Hemodiafiltration(HDF) on Vascular Health in Chronic Hemodialysis Patients | Unknown status | NCT00532597 | Phase 4 | | 12 | Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation | Unknown status | NCT00807144 | Phase 4 | | 13 | Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis | Unknown status | NCT00155363 | Phase 4 | | 14 | Acid-Base Composition With Use of Hemodialysates | Unknown status | NCT02334267 | Phase 4 | | 15 | Body Composition Monitor in Hemodialysis Patients | Unknown status | NCT01103167 | Phase 4 | | 16 | RAAS Inhibitor Drugs in Dialysis Patients | Unknown status | NCT01635387 | Phase 4 | | 17 | Hypervolemia in ESRD Patients in Zonguldak (Prospective Study) | Unknown status | NCT01468363 | Phase 4 | | 18 | Cardiovascular Protective Effect of Spironolactone in Hemodialysis | Unknown status | NCT00277693 | Phase 4 | | 19 | Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans | Unknown status | NCT00189202 | Phase 4 | | 20 | Open-label, Randomized Trial to Determine the Effect of Icodextrin Versus Dextrose (Dianeal 2.5%) in HOMA IR | Unknown status | NCT01093547 | Phase 4 | | 21 | The Canadian Prevention of Renal and Cardiovascular Endpoints Trial | Unknown status | NCT00231803 | Phase 4 | | 22 | More Frequent Dialysis (>3 Treatments Per Week) | Unknown status | NCT00575497 | Phase 4 | | 23 | Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients | Unknown status | NCT01111422 | Phase 4 | | 24 | 2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula | Unknown status | NCT00993746 | Phase 4 | | 25 | Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease | Unknown status | NCT01155128 | Phase 4 | | 26 | Far Infrared Therapy on Peripheral Artery Disease in Hemodialysis Patients | Unknown status | NCT01095549 | Phase 4 | | 27 | The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis | Unknown status | NCT02105519 | Phase 4 | | 28 | Efficacy of Pregabalin in the Management of Chronic Uremic Pruritus | Unknown status | NCT01073501 | Phase 4 | | 29 | Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy | Unknown status | NCT01175486 | Phase 4 | | 30 | Alendronate for Vascular Calcification in Peritoneal Dialysis Patients? | Unknown status | NCT00299572 | Phase 4 | | 31 | The Effect of Uric Acid Lowering in Type 1 Diabetes | Unknown status | NCT02344602 | Phase 4 | | 32 | Clinical Impact of Bacteriuria on Chronic Inflammation in Asymptomatic Hemodialysis Patients | Unknown status | NCT01570556 | Phase 4 | | 33 | Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy | Unknown status | NCT01673204 | Phase 4 | | 34 | Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy | Unknown status | NCT00939913 | Phase 4 | | 35 | Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function | Unknown status | NCT01977430 | Phase 4 | | 36 | The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients | Unknown status | NCT00247507 | Phase 4 | | 37 | Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin. | Unknown status | NCT00404599 | Phase 4 | | 38 | Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy | Unknown status | NCT00861731 | Phase 4 | | 39 | Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy | Unknown status | NCT01023373 | Phase 4 | | 40 | Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis (SBP) | Unknown status | NCT00761098 | Phase 4 | | 41 | Fibrosis in Renal Allografts | Unknown status | NCT00493194 | Phase 4 | | 42 | Placebo Controlled Study of Baclofen for GERD in Children With Cerebral Palsy | Unknown status | NCT01386255 | Phase 4 | | 43 | Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal | Unknown status | NCT00896012 | Phase 4 | | 44 | Quadripolar Leads for the Management of Heart Failure Patients in the Middle East | Unknown status | NCT02195843 | Phase 4 | | 45 | Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure | Completed | NCT00124969 | Phase 4 | | 46 | Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease | Completed | NCT01974817 | Phase 4 | | 47 | Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5 | Completed | NCT02392208 | Phase 4 | | 48 | Parathyroidectomy in Endstage Renal Disease | Completed | NCT00745719 | Phase 4 | | 49 | Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure | Completed | NCT00391287 | Phase 4 | | 50 | Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis | Completed | NCT00111995 | Phase 4 |
Inferred drug relations via UMLS68/NDF-RT46:
|
